div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5page1jpg target=_blank img data-url=2019-06-05-021-3163497-anm-m-16-05-201s-34-in-asociere-capecitabinas-la-pacientiihtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: · 2019-06-05 · 021-3163497 ANM M 16-05-201S 34 in asociere capecitabinas la pacientii cu neoplasm mamar avansat sau progresiv în unna unor teiapii anterioare care trebuie loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5thumbnails1jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imagea href=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5page2jpg target=_blank img data-url=2019-06-05-021-3163497-anm-m-16-05-201s-34-in-asociere-capecitabinas-la-pacientiihtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: · 2019-06-05 · 021-3163497 ANM M 16-05-201S 34 in asociere capecitabinas la pacientii cu neoplasm mamar avansat sau progresiv în unna unor teiapii anterioare care trebuie loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5thumbnails2jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imagea href=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5page3jpg target=_blank img data-url=2019-06-05-021-3163497-anm-m-16-05-201s-34-in-asociere-capecitabinas-la-pacientiihtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: · 2019-06-05 · 021-3163497 ANM M 16-05-201S 34 in asociere capecitabinas la pacientii cu neoplasm mamar avansat sau progresiv în unna unor teiapii anterioare care trebuie loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5thumbnails3jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imagea href=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5page4jpg target=_blank img data-url=2019-06-05-021-3163497-anm-m-16-05-201s-34-in-asociere-capecitabinas-la-pacientiihtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: · 2019-06-05 · 021-3163497 ANM M 16-05-201S 34 in asociere capecitabinas la pacientii cu neoplasm mamar avansat sau progresiv în unna unor teiapii anterioare care trebuie loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentecomreader030viewer20220218005e4e31505a9c3003cd2b43d5html5thumbnails4jpg width=140 height=200 adivdiv